Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Accenture
Chubb
Chinese Patent Office
Cipla
Teva
Argus Health
Deloitte
Healthtrust
Cerilliant

Generated: February 20, 2018

DrugPatentWatch Database Preview

ALYACEN 7/7/7 Drug Profile

« Back to Dashboard

When do Alyacen 7/7/7 patents expire, and when can generic versions of Alyacen 7/7/7 launch?

Alyacen 7/7/7 is a drug marketed by Glenmark Generics and is included in one NDA.

The generic ingredient in ALYACEN 7/7/7 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

US Patents and Regulatory Information for ALYACEN 7/7/7

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics ALYACEN 7/7/7 ethinyl estradiol; norethindrone TABLET;ORAL-28 091636-001 Jan 19, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Baxter
Merck
Daiichi Sankyo
Fish and Richardson
Queensland Health
Cipla
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot